JP2010500375A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500375A5
JP2010500375A5 JP2009523983A JP2009523983A JP2010500375A5 JP 2010500375 A5 JP2010500375 A5 JP 2010500375A5 JP 2009523983 A JP2009523983 A JP 2009523983A JP 2009523983 A JP2009523983 A JP 2009523983A JP 2010500375 A5 JP2010500375 A5 JP 2010500375A5
Authority
JP
Japan
Prior art keywords
stage
particle
stage particle
composition
nanoporous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009523983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/075516 external-priority patent/WO2008021908A2/en
Publication of JP2010500375A publication Critical patent/JP2010500375A/ja
Publication of JP2010500375A5 publication Critical patent/JP2010500375A5/ja
Pending legal-status Critical Current

Links

JP2009523983A 2006-08-08 2007-08-08 活性剤の多段階送達 Pending JP2010500375A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82175006P 2006-08-08 2006-08-08
US91434807P 2007-04-27 2007-04-27
PCT/US2007/075516 WO2008021908A2 (en) 2006-08-08 2007-08-08 Multistage delivery of active agents

Publications (2)

Publication Number Publication Date
JP2010500375A JP2010500375A (ja) 2010-01-07
JP2010500375A5 true JP2010500375A5 (https=) 2010-09-24

Family

ID=39082940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523983A Pending JP2010500375A (ja) 2006-08-08 2007-08-08 活性剤の多段階送達

Country Status (8)

Country Link
US (4) US20080311182A1 (https=)
EP (1) EP2056794A4 (https=)
JP (1) JP2010500375A (https=)
CN (1) CN101652126B (https=)
AU (1) AU2007286203B2 (https=)
CA (1) CA2664919A1 (https=)
MX (1) MX2009001461A (https=)
WO (1) WO2008021908A2 (https=)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006033679A2 (en) 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
US7854944B2 (en) * 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
CA2648581A1 (en) 2006-04-07 2008-09-12 Chimeros, Inc. Compositions and methods for treating b- cell malignancies
US8563022B2 (en) * 2006-10-11 2013-10-22 Board Of Regents Of The University Of Texas System Particles for cell targeting
WO2008106350A1 (en) * 2007-02-26 2008-09-04 Board Of Regents Of The University Of Texas System Endocytotic particles
US8920625B2 (en) 2007-04-27 2014-12-30 Board Of Regents Of The University Of Texas System Electrochemical method of making porous particles using a constant current density
CA2722183C (en) * 2008-04-25 2018-09-18 Northwestern University Nanostructures suitable for sequestering cholesterol and other molecules
US8173115B2 (en) 2008-07-29 2012-05-08 The Board Of Regents Of The University Of Texas System Particle compositions with a pre-selected cell internalization mode
CA2732252A1 (en) * 2008-07-29 2010-02-04 Paolo Decuzzi Particle compositions with a pre-selected cell internalization mode
US20110213193A1 (en) * 2008-08-28 2011-09-01 The Florida International University Board Of Trustees Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier
EP2373292A1 (en) * 2008-12-23 2011-10-12 Board of Regents of the University of Texas System Inflammation targeting particles
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
US20120045396A1 (en) * 2009-01-15 2012-02-23 Board Of Regents Of The University Of Texas System Porous structures with modified biodegradation kinetics
EP2398462A4 (en) * 2009-02-18 2012-07-25 Aradigm Corp PH-MODULATED FORMULATIONS FOR PULMONARY ADMINISTRATION
US8808733B2 (en) 2009-03-31 2014-08-19 The Board Of Trustees Of The University Of Arkansas Method of controlled drug release from a liposome carrier
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
BRPI1011269A2 (pt) * 2009-05-05 2016-09-27 Altermune Technologies Llc imunidade quimicamente programável
FR2948024B1 (fr) * 2009-07-17 2020-01-10 Centre National De La Recherche Scientifique - Cnrs - Emulsion activable par ultrasons et son procede de fabrication.
CA2775324C (en) * 2009-09-23 2018-05-15 Crystalplex Corporation Passivated nanoparticles
ES2367959B1 (es) * 2009-12-22 2013-01-24 Centro De Investigación Biomédica En Red En Bioingeniería, Biomateriales Y Nanomedicina Particulas magnético-luminiscentes para aplicaciones biomédicas.
WO2011091065A2 (en) 2010-01-19 2011-07-28 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
CN102858367B (zh) 2010-02-26 2014-12-17 国立大学法人长崎大学 抗原或药物递送复合物
US8568877B2 (en) 2010-03-09 2013-10-29 Board Of Regents Of The University Of Texas System Porous and non-porous nanostructures
WO2011116237A1 (en) * 2010-03-17 2011-09-22 Board Of Regents Of The University Of Texas System Universal cell-directed theranostics
EP2590605A1 (en) 2010-07-09 2013-05-15 Board of Regents of the University of Texas System Biodegradable scaffolds
WO2012021922A1 (en) * 2010-08-16 2012-02-23 Australian Nuclear Science & Technology Organisation Particulate substances comprising ceramic particles for delivery of biomolecules
US20130224282A1 (en) * 2010-09-21 2013-08-29 Massachusetts Institute Of Technology Multistage Nanoparticles
RU2475233C2 (ru) * 2010-12-01 2013-02-20 Учреждение Российской академии наук Институт кристаллографии им. А.В. Шубникова РАН Фармакологическая композиция, предназначенная для интраназального введения с целью доставки в мозг фармакологически активного компонента, и способ ее получения
EP2697162B1 (en) 2011-04-14 2020-12-02 The Regents of The University of California Multifunctional nanoparticle designs and applications
CN103998932B (zh) 2011-06-29 2017-06-06 中央研究院 使用表面涂层对生物物质的捕获、纯化和释放
US9101547B2 (en) 2011-08-04 2015-08-11 Nano And Advanced Materials Institute Limited Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery
US8859004B2 (en) 2011-08-04 2014-10-14 Nano And Advanced Materials Institute Limited pH-sensitive nanoparticles for oral insulin delivery
CA2847888A1 (en) 2011-09-09 2013-03-14 Biomed Realty, L.P. Methods and compositions for controlling assembly of viral proteins
WO2013095736A2 (en) * 2011-09-27 2013-06-27 The Methodist Hospital Research Institute Gold-in-silicon nanoassembly for thermal therapy and methods of use
WO2013070872A1 (en) 2011-11-08 2013-05-16 The Board Of Trustees Of The University Of Arkansas Methods and compositions for x-ray induced release from ph sensitive liposomes
US8926994B2 (en) * 2011-12-07 2015-01-06 The Methodist Hospital Research Institute Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity
US20130304050A1 (en) * 2012-05-10 2013-11-14 Wake Forest University Health Sciences Methods of treating cancerous tissue
US10842749B2 (en) * 2012-06-12 2020-11-24 The Methodist Hospital Research Institute Compositions and methods of treating therapy resistant cancer and uses thereof
US8883216B2 (en) 2012-08-27 2014-11-11 Red Lion Chem Tech, Llc Methods and ceramic nanoparticle compositions for heavy metal removal and for oral delivery of desirable agents
US20140120157A1 (en) * 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
CA2912975A1 (en) * 2012-10-16 2014-04-24 William Marsh Rice University An improved nanovector based drug delivery system for overcoming drug resistance
US20170136123A1 (en) * 2013-01-10 2017-05-18 Amrita Vishwa Vidyapeetham Stannous doped micro and nano particles for augmented radiofrequency ablation
JP2015007209A (ja) * 2013-05-31 2015-01-15 株式会社リコー コアシェル型粒子、及びその製造方法
CN105579582A (zh) 2013-07-25 2016-05-11 埃克西奎雷股份有限公司 用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体
WO2015023797A1 (en) 2013-08-13 2015-02-19 Northwestern University Lipophilic nanoparticles for drug delivery
US20160279187A1 (en) * 2013-10-31 2016-09-29 University Of Hawaii Calpain inhibitors for ibd and colorectal cancer treatment
JP6527516B2 (ja) 2013-12-03 2019-06-05 ノースウェスタン ユニバーシティ リポソーム粒子、前述のものを作製する方法及びその使用
WO2015153816A2 (en) 2014-04-01 2015-10-08 Academia Sinica Methods and systems for cancer diagnosis and prognosis
WO2015176025A1 (en) 2014-05-15 2015-11-19 The Methodist Hospital Discoidal polymeric nanoconstructs and methods of use in cancer theranostics
EP3971262B1 (en) 2014-05-29 2024-04-24 Tectus Corporation Dispersion system for quantum dots
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
EP3173074A4 (en) 2014-07-22 2018-03-07 Lemonex Inc. Composition for delivering bioactive material or protein, and use thereof
WO2016028940A1 (en) 2014-08-19 2016-02-25 Northwestern University Protein/oligonucleotide core-shell nanoparticle therapeutics
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
MX2017003903A (es) 2014-10-03 2017-09-15 Ntercept Llc Composiciones y metodos para inhibir la actividad biologica de biomoleculas solubles.
CA2963931A1 (en) 2014-10-06 2016-04-14 Exicure, Inc. Anti-tnf compounds
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
CA2977397A1 (en) 2015-03-03 2016-09-09 Cureport, Inc. Dual loaded liposomal pharmaceutical formulations
CN107530283A (zh) 2015-03-03 2018-01-02 奎尔波特股份有限公司 组合脂质体药物制剂
US10078092B2 (en) 2015-03-18 2018-09-18 Northwestern University Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
CN114533898B (zh) * 2015-07-09 2025-07-01 加利福尼亚大学董事会 融合脂质体包被的多孔硅纳米颗粒
US20170056327A1 (en) * 2015-08-25 2017-03-02 The Methodist Hospital Micro/nano composite drug delivery formulations and uses thereof
ITUB20159209A1 (it) 2015-12-21 2017-06-21 Fidia Farm Spa Nanosistemi per il trasporto controllato di molecole attive a fini diagnostici, prognostici e terapeutici
EP3426301A4 (en) * 2016-03-08 2019-11-06 Los Gatos Pharmaceuticals, Inc. VERBUNDNANOPARTICLES AND USES THEREOF
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
EP3452598A4 (en) 2016-05-06 2020-04-29 Exicure, Inc. LIPOSOMAL SPHERICAL NUCLEIC ACID (ANS) CONSTRUCTS HAVING ANTISENSE OLIGONUCLEOTIDES (ASO) FOR THE SPECIFIC INACTIVATION OF INTERLEUKIN 17 RECEPTOR RNA
US20190177615A1 (en) 2016-05-19 2019-06-13 Crystalplex Corporation Cadmium-free quantum dots, tunable quantum dots, quantum dot containing polymer, articles, films, and 3d structure containing them and methods of making and using them
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
US11065345B2 (en) 2017-01-04 2021-07-20 Nanotics, Llc Methods for assembling scavenging particles
KR20180091768A (ko) 2017-02-06 2018-08-16 주식회사 레모넥스 생리활성물질 전달체
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties
JP2020526558A (ja) 2017-07-13 2020-08-31 ノースウェスタン ユニバーシティ オリゴヌクレオチド官能化金属有機構造体ナノ粒子を調製するための一般的かつ直接的な方法
US20200163885A1 (en) * 2017-07-25 2020-05-28 Lemonex Inc. Composition for delivering physiologically active ingredients into blood vessel
KR102152348B1 (ko) 2017-09-05 2020-09-08 주식회사 레모넥스 세포 운명 조절용 조성물
KR102729931B1 (ko) 2017-12-19 2024-11-13 나노비오?笭? 신경 장애의 치료에서 사용하기 위한 나노입자
EP4461363A3 (en) 2017-12-19 2025-01-08 Nanobiotix Nanoparticles for use in enhancing brain performances or in treating stress
WO2019157319A1 (en) * 2018-02-12 2019-08-15 Flagship Pioneering Innovations V, Inc. Devices and methods for delivering material into a biological tissue or cell
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids
CN112546406B (zh) * 2020-11-20 2022-04-22 广东药科大学 一种微型机器人给药装置及给药系统
WO2024035784A1 (en) * 2022-08-10 2024-02-15 Auburn University Shrinking nanomaterial for biomedical applications

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4933185A (en) 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US5010167A (en) 1989-03-31 1991-04-23 Massachusetts Institute Of Technology Poly(amide-and imide-co-anhydride) for biological application
US6099864A (en) 1994-12-02 2000-08-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration In situ activation of microcapsules
US6107102A (en) 1995-06-07 2000-08-22 Regents Of The University Of California Therapeutic microdevices and methods of making and using same
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
ES2130056B1 (es) * 1997-01-16 2000-02-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad oral de drogas de dificil absorcion.
WO2000030592A1 (en) * 1998-11-20 2000-06-02 The General Hospital Corporation Permanent, removable tissue markings
US6355270B1 (en) * 1999-01-11 2002-03-12 The Regents Of The University Of California Particles for oral delivery of peptides and proteins
US20030114366A1 (en) * 1999-01-11 2003-06-19 Francis J. Martin Microfabricated particles and method for treating solid tumors
US6887493B2 (en) * 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
US6685927B2 (en) * 2001-09-27 2004-02-03 Ceramoptec Industries, Inc. Topical application of chromophores for hair removal
US7563451B2 (en) * 2003-07-22 2009-07-21 Iowa State University Research Foundation, Inc. Capped mesoporous silicates
JP2007526322A (ja) * 2004-03-02 2007-09-13 マサチューセッツ インスティテュート オブ テクノロジー ナノセル薬物送達系
US8753897B2 (en) 2005-12-20 2014-06-17 The Board Of Regents Of The University Of Texas System Nanoporous substrates for the analytical methods
US20090311295A1 (en) * 2006-05-12 2009-12-17 Edith Mathiowitz Particles with high uniform loading of nanoparticles and methods of preparation thereof
WO2008041970A2 (en) * 2006-09-28 2008-04-10 Board Of Regents Of The University Of Texas System Methods and compositions for targeting fenestrated vasculature
US8563022B2 (en) * 2006-10-11 2013-10-22 Board Of Regents Of The University Of Texas System Particles for cell targeting
US8920625B2 (en) * 2007-04-27 2014-12-30 Board Of Regents Of The University Of Texas System Electrochemical method of making porous particles using a constant current density

Similar Documents

Publication Publication Date Title
JP2010500375A5 (https=)
Batool et al. A detailed insight of the tumor targeting using nanocarrier drug delivery system
Cheng et al. A multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo/gene/photothermal therapy
Maleki et al. The progress and prospect of zeolitic imidazolate frameworks in cancer therapy, antibacterial activity, and biomineralization
Pan et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles
Hasan et al. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer
Zou et al. Virus‐mimicking chimaeric polymersomes boost targeted cancer siRNA therapy in vivo
Zeng et al. A drug‐self‐gated mesoporous antitumor nanoplatform based on pH‐sensitive dynamic covalent bond
Cattaneo et al. Nanotechnology and human health: risks and benefits
He et al. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility
Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic
Knežević et al. Targeted treatment of cancer with nanotherapeutics based on mesoporous silica nanoparticles
Dong et al. Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide–PEG conjugates
Athar et al. Therapeutic nanoparticles: State-of-the-art of nanomedicine
ES2776126T3 (es) Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
Lindén Biodistribution and excretion of intravenously injected mesoporous silica nanoparticles: implications for drug delivery efficiency and safety
Liu et al. Harnessing the collective properties of nanoparticle ensembles for cancer theranostics
Yang et al. Soft and condensed nanoparticles and nanoformulations for cancer drug delivery and repurpose
Ge et al. Human albumin fragments nanoparticles as PTX carrier for improved anti-cancer efficacy
Parmar et al. Factors affecting the clearance and biodistribution of polymeric nanoparticles
Yang et al. Recent advances of pH‐induced charge‐convertible polymer‐mediated inorganic nanoparticles for biomedical applications
Zhang et al. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus
Thotakura et al. Assessing the pharmacokinetics and toxicology of polymeric micelle conjugated therapeutics
Han et al. Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury
Martin-Palma et al. Nanostructured porous silicon-mediated drug delivery